Upheaval has forged a uniquely flexible, adaptable faction of emerging talent entering the workforce, says Michal Katz, Head of Investment & Corporate Banking. She provides a few pieces of advice for recent graduates navigating this next phase of their lives.

With more than half of the world’s economic output dependent on nature, biodiversity loss poses immense challenges for people, business, and the financial system. David Craig, co-chair of the new Taskforce on Nature-Related Financial Disclosures (TNFD), joined Mark Wheatcroft, Head of Sustainability, Mizuho EMEA, to discuss how we can help manage nature-related risks, shift financial flows, and create opportunities linking the environment and investment.

Utilities have long been a defensive investment option in troubled times, which has certainly held true this year. Senior Electric Utilities analyst Anthony Crowdell discusses the factors contributing to the sector’s outperformance and the companies with higher growth potential.

At Mizuho, we recognize the important of integrating environmental, social and governance (ESG) factors across our business, and strive to further embed sustainability into our strategy and culture. In our latest video for Mizuho staff, we highlight our firm-wide sustainability initiatives to help raise awareness, encourage action, and increase our positive impact on our local communities and society more broadly.

Issuers, for the most part, were willing to sit this quarter out, say Kevin Davies and Stephen Roney, Healthcare Investment & Corporate Banking. They provide a detailed look at the healthcare market’s rough Q1, and advice for issuers on the path forward.

With energy markets experiencing disruptions on a scale not seen in decades, there was plenty to talk about at Mizuho’s fourth annual rating agency panel, which focused on prospects for production growth and the adequacy of infrastructure investments to keep up with shifting energy flows. Michael Gorelick, Head of Ratings Advisory, provides key highlights.

Facing a multitude of macro headwinds ranging from ongoing inflationary pressures to geopolitical tensions, equity markets have been quite turbulent. Head of TMT ECM & SPAC Origination Andy Laszlo recaps the TMT market over the first quarter.

After reaching historically-high multiples in 2021, a shift in biotech funding is raising doubts about the industry’s growth prospects. Investors are overlooking positive signs, argues Ann Hynes, Senior US Healthcare Equity Research Analyst.

Investors might be wary about the industrial sector after two years of unprecedented supply chain disruptions and record cost inflation, but the landscape is slowly improving. Senior US Industrials Analyst Brett Linzey looks at the current state of the market and examines longer-term secular trends.